© 2023 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2023 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
December 03, 2016
Melanoma should not be considered to be in a "special category" that responds well to immunotherapy, according to Christian M. Capitini, M.D., assistant professor of Pediatrics at the University of Wisconsin.
Obe-cel Leads to Deep, Durable Responses in B-Cell ALL
Simple Hysterectomy ‘the New Standard’ for Low-Risk, Early Cervical Cancer
Final Open Mic Showcase Features Cancer Comedy, Other Acts
The Other Side of Shared Cancer Experiences